|

[68Ga]Ga-NNS309 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Novartis Pharmaceuticals1

Indications

  • HR+/HER2- Ductal and Lobular Breast Cancer1
  • Pancreatic Ductal Adenocarcinoma1
  • Triple Negative Breast Cancer1
  • Colorectal Cancer1
  • Lung Cancer1

Birmingham, Alabama1 trial

Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers

Uni of Alabama at Birmingham

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.